[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.55.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 21, 1977

Peripheral Diabetic Neuropathy Treated With Amitriptyline and Fluphenazine

Author Affiliations

USNR; USNR; USNR; USNR; USNR; USN
From the Clinical Investigation Center, Naval Regional Medical Center, Oakland, Calif. Dr Gerich is now with the Diabetes and Metabolism Research Laboratory, Mayo Clinic, Rochester, Minn.

JAMA. 1977;238(21):2291-2292. doi:10.1001/jama.1977.03280220059023
Abstract

The pain of diabetic peripheral neuropathy responds poorly to current modes of treatment. We treated eight patients with this disorder whose pain was refractory to standard regimens but who experienced remarkable pain relief within two to five days after treatment with fluphenazine hydrochloride, amitriptyline hydrochloride, or a combination of the two. In four patients whose regimens were discontinued, pain recurred within two days and again remitted on reinstitution of the drug regimens. These findings suggest that fluphenazine alone or in combination with amitriptyline may be of benefit in treating the painful peripheral neuropathy associated with diabetes.

(JAMA 238:2291-2292, 1977)

×